Oncorena AB
Oncorena AB is a Swedish pharma company founded in 2011, in Gothenburg, with the mission to develop a breakthrough treatment for metastatic renal cancer headquartered in Lund.
Our objective is to confirm the powerful anti-tumor activity in preclinical studies and evaluate potential clinical benefits of ONC175 in metastatic renal cancer patients.

